Results 171 to 180 of about 519,396 (228)

Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System. [PDF]

Ther Adv Neurol Disord
Shirani A, Goldlust SA, Stuve O.
europepmc   +1 more source

Analysis of Adverse Events Following Phenobarbital Administration for Pediatric Patients Categorized by One-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System [PDF]

Toru Ogura, Chihiro Shiraishi
openalex   +1 more source

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system. [PDF]

Front Pharmacol
Huang T, Zhang P, Zhou Y, Wang L, Zhang Q, Li M, Xiao J.   +6 more
europepmc   +1 more source

The real-world safety of lacosamide and perampanel in children: a disproportionality analysis of the FDA Adverse Event Reporting System. [PDF]

Ther Adv Drug Saf
Tan Y, Li C, Yi Q, Liu X, Yang Y, Zheng L, Wei L, Huang L.   +7 more
europepmc   +1 more source

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system [PDF]

Jinming Cao, Zhicong Chen, Yan Wang, Yunpeng Ma, Zhen Yang, Jian Cai, Zhijun Xiao, Xu Feng   +7 more
openalex   +1 more source

A comprehensive study on drug-related Raynaud's phenomenon based on the FDA adverse event reporting system. [PDF]

Sci Rep
Zheng P, Zheng X, Chen Q, Wang D, Huang L, Lin J, Chen S.   +6 more
europepmc   +1 more source

Table 4_A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data.xlsx

Baiqing Huang (22833065), Yirou Ma (22833068), Wenli Wang (1701169), Shaorui Gu (9185111), Xisheng Wang (1988002)   +4 more
openalex   +1 more source

Characteristics of adverse events and clinical risks of intravenous immunoglobulin: a pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS). [PDF]

Front Med (Lausanne)
Lu Z, Lu X, Gao Y, Shang G, Zeng Y.
europepmc   +1 more source

Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database

Shiju Wei, Zhenyu Zhang, Song Xuhua, Rui Chen, Siyu Chen, Baoping Lu   +5 more
openalex   +1 more source

Correction: An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System. [PDF]

Drug Saf
Janiczak S, Tanveer S, Tom K, Zhang R, Ma Y, Wolf L, Muñoz MA.   +6 more
europepmc   +1 more source